AGÕæÈ˹ٷ½

STOCK TITAN

[8-K] Comstock Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Comstock Inc. amended multiple promissory notes and warrants and entered a payoff agreement while disclosing preliminary H1 2025 results. The Company issued 2,900,000 restricted shares as partial consideration to address an aggregate $8,390,000 of promissory note principal, and will file a registration statement for those shares within 90 days. If share sale proceeds plus prior cash payments do not fully repay the notes, a true-up payment may be due on April 15, 2026 with interest at 12% per annum. Comstock also extended 220,000 warrants exercisable at $4.56 to December 31, 2027. Under a payoff letter, the Company settled a $10,638,298 convertible note by paying $2,500,000 cash and issuing 447,724 shares subject to a lock-up through October 31, 2025. Preliminary results show $18.6 million in cash, revenue of $0.3 million for the quarter and $1.1 million for six months, and recurring net losses of $7.8 million (quarter) and $16.9 million (six months). Two officers resigned to join Bioleum Corporation.

Comstock Inc. ha modificato più cambiali e warrant e ha stipulato un accordo di estinzione del debito contestualmente alla comunicazione dei risultati preliminari del primo semestre 2025. La Società ha emesso 2.900.000 azioni soggette a restrizioni come parte del corrispettivo per coprire un ammontare aggregato di 8.390.000$ di capitale dei pagherò e depositerà una dichiarazione di registrazione per queste azioni entro 90 giorni. Se i proventi dalla vendita delle azioni più i precedenti pagamenti in contanti non estingueranno interamente le cambiali, potrebbe essere dovuto un pagamento di aggiustamento il 15 aprile 2026 con interessi al 12% annuo. Comstock ha inoltre prorogato 220.000 warrant esercitabili a 4,56$ fino al 31 dicembre 2027. In base a una lettera di pagamento, la Società ha estinto un'obbligazione convertibile di 10.638.298$ pagando 2.500.000$ in contanti e emettendo 447.724 azioni soggette a lock-up fino al 31 ottobre 2025. I risultati preliminari indicano 18,6 milioni di dollari in cassa, ricavi per 0,3 milioni nel trimestre e 1,1 milioni nei sei mesi, e perdite nette ricorrenti di 7,8 milioni (trimestre) e 16,9 milioni (sei mesi). Due dirigenti si sono dimessi per unirsi a Bioleum Corporation.

Comstock Inc. modificó varios pagarés y warrants y celebró un acuerdo de pago al tiempo que divulgaba resultados preliminares del primer semestre de 2025. La Compañía emitió 2.900.000 acciones restringidas como parte del pago para cubrir un saldo agregado de 8.390.000$ de principal de los pagarés, y presentará una declaración de registro para esas acciones dentro de 90 días. Si los ingresos por venta de acciones más pagos en efectivo previos no cubren íntegramente las notas, podría vencer un pago de ajuste el 15 de abril de 2026 con intereses al 12% anual. Comstock también extendió 220.000 warrants ejercitables a 4,56$ hasta el 31 de diciembre de 2027. Según una carta de pago, la Compañía saldó un pagaré convertible de 10.638.298$ pagando 2.500.000$ en efectivo y emitiendo 447.724 acciones sujetas a un periodo de bloqueo hasta el 31 de octubre de 2025. Los resultados preliminares muestran 18,6 millones de dólares en efectivo, ingresos de 0,3 millones en el trimestre y 1,1 millones en seis meses, y pérdidas netas recurrentes de 7,8 millones (trimestre) y 16,9 millones (seis meses). Dos directivos renunciaron para unirse a Bioleum Corporation.

Comstock Inc.ëŠ� 여러 약ì†ì–´ìŒê³� 워런트를 수정하고 ìƒí™˜ í•©ì˜(payoff agreement)ë¥� 체결하면ì„� 2025 íšŒê³„ì—°ë„ ìƒë°˜ê¸� 예비 실ì ì� 공시했습니다. 회사ëŠ� ì•� 8,390,000달러ì� 약ì†ì–´ìŒ ì›ê¸ˆ ì¼ë¶€ë¥� ìƒí™˜í•˜ê¸° 위해 2,900,000ì£¼ì˜ ì œí•œë¶€ 주ì‹ì� 발행했으ë©�, 해당 주ì‹ì—� 대í•� 등ë¡ì‹ ê³ ì„œë¥¼ 90ì� ì´ë‚´ì—� 제출í•� 예정입니ë‹�. ì£¼ì‹ ë§¤ê° ìˆ˜ìµê³� 기존 현금 지급액으로 ì–´ìŒì� ì „ì•¡ ìƒí™˜ë˜ì§€ ì•Šì„ ê²½ìš° 2026ë…� 4ì›� 15ì¼ì— ì •ì‚°ê¸ˆì´ ë°œìƒí•� ìˆ� 있으ë©� ì—� 12%ì� ì´ìžê°€ ì ìš©ë©ë‹ˆë‹�. Comstockì€ í–‰ì‚¬ê°€ 4.56달러ì� 220,000ê°œì˜ ì›ŒëŸ°íŠ¸ì˜ í–‰ì‚¬ê¸°ê°„ì� 2027ë…� 12ì›� 31ì¼ê¹Œì§€ 연장했습니다. ìƒí™˜ í•©ì˜ì„œì— ë”°ë¼ íšŒì‚¬ëŠ� 10,638,298달러ì� 전환사채ë¥� 2,500,000달러 현금 지급과 447,724ì£� 발행으로 정리했으ë©�, ì� 주ì‹ì€ 2025ë…� 10ì›� 31ì¼ê¹Œì§€ ë½ì—…(매ê°ì œí•œ) ìƒíƒœìž…니ë‹�. 예비 실ì ì€ 현금 1,860ë§� 달러, 분기 매출 30ë§� 달러, 반기 매출 110ë§� 달러, 반복ì � 순ì†ì‹¤ì´ 분기 기준 780ë§� 달러 ë°� 반기 기준 1,690ë§� ë‹¬ëŸ¬ìž„ì„ ë³´ì—¬ì¤ë‹ˆë‹�. ë‘� ìž„ì›ì� Bioleum Corporationì—� 합류하기 위해 사임했습니다.

Comstock Inc. a modifié plusieurs billets à ordre et warrants et a conclu un accord de règlement tout en divulguant des résultats préliminaires du premier semestre 2025. La Société a émis 2 900 000 actions restreintes en contrepartie partielle pour couvrir un montant principal agrégé de 8 390 000$ de billets à ordre, et déposera une déclaration d'enregistrement pour ces actions dans les 90 jours. Si les produits de la vente des actions, additionnés des paiements en numéraire antérieurs, ne remboursent pas intégralement les billets, un paiement d'ajustement pourrait être exigible le 15 avril 2026 avec des intérêts de 12% par an. Comstock a également prolongé 220 000 warrants exerçables à 4,56$ jusqu'au 31 décembre 2027. En vertu d'une lettre d'acquittement, la Société a soldé un billet convertible de 10 638 298$ en versant 2 500 000$ en espèces et en émettant 447 724 actions soumises à une période de lock-up jusqu'au 31 octobre 2025. Les résultats préliminaires indiquent 18,6 M$ de trésorerie, un chiffre d'affaires de 0,3 M$ sur le trimestre et 1,1 M$ sur six mois, et des pertes nettes récurrentes de 7,8 M$ (trimestre) et 16,9 M$ (six mois). Deux dirigeants ont démissionné pour rejoindre Bioleum Corporation.

Comstock Inc. hat mehrere Schuldscheine und Warrants geändert und eine Ausgleichsvereinbarung getroffen, während vorläufige Zahlen für das erste Halbjahr 2025 veröffentlicht wurden. Das Unternehmen gab 2.900.000 eingeschränkte Aktien als Teil der Gegenleistung zur Begleichung eines aggregierten Nominalbetrags von 8.390.000$ an Schuldverschreibungen aus und wird innerhalb von 90 Tagen eine Registrierungs­erklärung für diese Aktien einreichen. Sollten die Erlöse aus Aktienverkäufen zuzüglich vorheriger Barzahlungen die Schulden nicht vollständig tilgen, könnte am 15. April 2026 eine Ausgleichszahlung fällig werden, mit Zinsen von 12% p.a. Comstock verlängerte außerdem 220.000 Warrants mit einem Ausübungspreis von 4,56$ bis zum 31. Dezember 2027. Unter einem Ausgleichsschreiben beglich das Unternehmen eine wandelbare Verbindlichkeit in Höhe von 10.638.298$ durch Zahlung von 2.500.000$ in bar und die Ausgabe von 447.724 Aktien, die einer Sperrfrist bis zum 31. Oktober 2025 unterliegen. Vorläufige Ergebnisse zeigen 18,6 Mio. $ liquide Mittel, Umsatzerlöse von 0,3 Mio. $ im Quartal und 1,1 Mio. $ in sechs Monaten sowie wiederkehrende Nettoverluste von 7,8 Mio. $ (Quartal) und 16,9 Mio. $ (sechs Monate). Zwei leitende Angestellte traten zurück, um zu Bioleum Corporation zu wechseln.

Positive
  • $18.6 million in cash and cash equivalents reported as of June 30, 2025, supporting liquidity
  • Debt restructuring addressed $8,390,000 of promissory principal through negotiated amendments and share issuance, reducing immediate cash strain
  • Note payoff with Kips Bay settles a $10,638,298 convertible note via $2,500,000 cash plus 447,724 shares, removing that outstanding obligation
Negative
  • Recurring net losses of $7.8 million for the quarter and $16.9 million for the six months ended June 30, 2025
  • Dilution risk from issuance of 2,900,000 restricted shares and 447,724 payoff shares; warrants extended to Dec 31, 2027 delaying potential cash exercises
  • True-up cash obligation could become payable on April 15, 2026 with interest at 12% if share sale proceeds plus cash payments do not fully repay notes
  • Executive departures of David Winsness and Rahul Bobbili who resigned to join Bioleum Corporation

Insights

TL;DR Debt was restructured to conserve cash but increased share dilution and left material recurring losses.

The Company converted part of $8.39M in promissory principal into 2.9M restricted shares and agreed to a potential April 15, 2026 true-up with 12% interest if share proceeds are insufficient. The Kips Bay payoff settles a $10.64M convertible note for $2.5M cash plus 447,724 shares, improving near-term liability certainty. Comstock reported $18.6M cash, which supports operations, but recurring net losses of $7.8M quarterly and $16.9M year-to-date indicate ongoing burn. Extending 220,000 warrants to 2027 delays potential cash from exercises and preserves optionality for warrant holders. Overall, liquidity is maintained but capital structure is more diluted and near-term profitability remains a concern.

TL;DR Significant creditor amendments and executive departures raise governance and stakeholder alignment issues.

The issuance of 2.9M restricted shares and the warrant extension reflect negotiated creditor accommodations that alter equity distribution and postpone potential warrant cash inflows until 2027. The true-up mechanics and 12% interest create contingent obligations that could require cash if equity sales fall short. The resignation of two officers to join another company is material for leadership continuity. These developments are material to investors evaluating board and management stability and the transparency of creditor arrangements.

Comstock Inc. ha modificato più cambiali e warrant e ha stipulato un accordo di estinzione del debito contestualmente alla comunicazione dei risultati preliminari del primo semestre 2025. La Società ha emesso 2.900.000 azioni soggette a restrizioni come parte del corrispettivo per coprire un ammontare aggregato di 8.390.000$ di capitale dei pagherò e depositerà una dichiarazione di registrazione per queste azioni entro 90 giorni. Se i proventi dalla vendita delle azioni più i precedenti pagamenti in contanti non estingueranno interamente le cambiali, potrebbe essere dovuto un pagamento di aggiustamento il 15 aprile 2026 con interessi al 12% annuo. Comstock ha inoltre prorogato 220.000 warrant esercitabili a 4,56$ fino al 31 dicembre 2027. In base a una lettera di pagamento, la Società ha estinto un'obbligazione convertibile di 10.638.298$ pagando 2.500.000$ in contanti e emettendo 447.724 azioni soggette a lock-up fino al 31 ottobre 2025. I risultati preliminari indicano 18,6 milioni di dollari in cassa, ricavi per 0,3 milioni nel trimestre e 1,1 milioni nei sei mesi, e perdite nette ricorrenti di 7,8 milioni (trimestre) e 16,9 milioni (sei mesi). Due dirigenti si sono dimessi per unirsi a Bioleum Corporation.

Comstock Inc. modificó varios pagarés y warrants y celebró un acuerdo de pago al tiempo que divulgaba resultados preliminares del primer semestre de 2025. La Compañía emitió 2.900.000 acciones restringidas como parte del pago para cubrir un saldo agregado de 8.390.000$ de principal de los pagarés, y presentará una declaración de registro para esas acciones dentro de 90 días. Si los ingresos por venta de acciones más pagos en efectivo previos no cubren íntegramente las notas, podría vencer un pago de ajuste el 15 de abril de 2026 con intereses al 12% anual. Comstock también extendió 220.000 warrants ejercitables a 4,56$ hasta el 31 de diciembre de 2027. Según una carta de pago, la Compañía saldó un pagaré convertible de 10.638.298$ pagando 2.500.000$ en efectivo y emitiendo 447.724 acciones sujetas a un periodo de bloqueo hasta el 31 de octubre de 2025. Los resultados preliminares muestran 18,6 millones de dólares en efectivo, ingresos de 0,3 millones en el trimestre y 1,1 millones en seis meses, y pérdidas netas recurrentes de 7,8 millones (trimestre) y 16,9 millones (seis meses). Dos directivos renunciaron para unirse a Bioleum Corporation.

Comstock Inc.ëŠ� 여러 약ì†ì–´ìŒê³� 워런트를 수정하고 ìƒí™˜ í•©ì˜(payoff agreement)ë¥� 체결하면ì„� 2025 íšŒê³„ì—°ë„ ìƒë°˜ê¸� 예비 실ì ì� 공시했습니다. 회사ëŠ� ì•� 8,390,000달러ì� 약ì†ì–´ìŒ ì›ê¸ˆ ì¼ë¶€ë¥� ìƒí™˜í•˜ê¸° 위해 2,900,000ì£¼ì˜ ì œí•œë¶€ 주ì‹ì� 발행했으ë©�, 해당 주ì‹ì—� 대í•� 등ë¡ì‹ ê³ ì„œë¥¼ 90ì� ì´ë‚´ì—� 제출í•� 예정입니ë‹�. ì£¼ì‹ ë§¤ê° ìˆ˜ìµê³� 기존 현금 지급액으로 ì–´ìŒì� ì „ì•¡ ìƒí™˜ë˜ì§€ ì•Šì„ ê²½ìš° 2026ë…� 4ì›� 15ì¼ì— ì •ì‚°ê¸ˆì´ ë°œìƒí•� ìˆ� 있으ë©� ì—� 12%ì� ì´ìžê°€ ì ìš©ë©ë‹ˆë‹�. Comstockì€ í–‰ì‚¬ê°€ 4.56달러ì� 220,000ê°œì˜ ì›ŒëŸ°íŠ¸ì˜ í–‰ì‚¬ê¸°ê°„ì� 2027ë…� 12ì›� 31ì¼ê¹Œì§€ 연장했습니다. ìƒí™˜ í•©ì˜ì„œì— ë”°ë¼ íšŒì‚¬ëŠ� 10,638,298달러ì� 전환사채ë¥� 2,500,000달러 현금 지급과 447,724ì£� 발행으로 정리했으ë©�, ì� 주ì‹ì€ 2025ë…� 10ì›� 31ì¼ê¹Œì§€ ë½ì—…(매ê°ì œí•œ) ìƒíƒœìž…니ë‹�. 예비 실ì ì€ 현금 1,860ë§� 달러, 분기 매출 30ë§� 달러, 반기 매출 110ë§� 달러, 반복ì � 순ì†ì‹¤ì´ 분기 기준 780ë§� 달러 ë°� 반기 기준 1,690ë§� ë‹¬ëŸ¬ìž„ì„ ë³´ì—¬ì¤ë‹ˆë‹�. ë‘� ìž„ì›ì� Bioleum Corporationì—� 합류하기 위해 사임했습니다.

Comstock Inc. a modifié plusieurs billets à ordre et warrants et a conclu un accord de règlement tout en divulguant des résultats préliminaires du premier semestre 2025. La Société a émis 2 900 000 actions restreintes en contrepartie partielle pour couvrir un montant principal agrégé de 8 390 000$ de billets à ordre, et déposera une déclaration d'enregistrement pour ces actions dans les 90 jours. Si les produits de la vente des actions, additionnés des paiements en numéraire antérieurs, ne remboursent pas intégralement les billets, un paiement d'ajustement pourrait être exigible le 15 avril 2026 avec des intérêts de 12% par an. Comstock a également prolongé 220 000 warrants exerçables à 4,56$ jusqu'au 31 décembre 2027. En vertu d'une lettre d'acquittement, la Société a soldé un billet convertible de 10 638 298$ en versant 2 500 000$ en espèces et en émettant 447 724 actions soumises à une période de lock-up jusqu'au 31 octobre 2025. Les résultats préliminaires indiquent 18,6 M$ de trésorerie, un chiffre d'affaires de 0,3 M$ sur le trimestre et 1,1 M$ sur six mois, et des pertes nettes récurrentes de 7,8 M$ (trimestre) et 16,9 M$ (six mois). Deux dirigeants ont démissionné pour rejoindre Bioleum Corporation.

Comstock Inc. hat mehrere Schuldscheine und Warrants geändert und eine Ausgleichsvereinbarung getroffen, während vorläufige Zahlen für das erste Halbjahr 2025 veröffentlicht wurden. Das Unternehmen gab 2.900.000 eingeschränkte Aktien als Teil der Gegenleistung zur Begleichung eines aggregierten Nominalbetrags von 8.390.000$ an Schuldverschreibungen aus und wird innerhalb von 90 Tagen eine Registrierungs­erklärung für diese Aktien einreichen. Sollten die Erlöse aus Aktienverkäufen zuzüglich vorheriger Barzahlungen die Schulden nicht vollständig tilgen, könnte am 15. April 2026 eine Ausgleichszahlung fällig werden, mit Zinsen von 12% p.a. Comstock verlängerte außerdem 220.000 Warrants mit einem Ausübungspreis von 4,56$ bis zum 31. Dezember 2027. Unter einem Ausgleichsschreiben beglich das Unternehmen eine wandelbare Verbindlichkeit in Höhe von 10.638.298$ durch Zahlung von 2.500.000$ in bar und die Ausgabe von 447.724 Aktien, die einer Sperrfrist bis zum 31. Oktober 2025 unterliegen. Vorläufige Ergebnisse zeigen 18,6 Mio. $ liquide Mittel, Umsatzerlöse von 0,3 Mio. $ im Quartal und 1,1 Mio. $ in sechs Monaten sowie wiederkehrende Nettoverluste von 7,8 Mio. $ (Quartal) und 16,9 Mio. $ (sechs Monate). Zwei leitende Angestellte traten zurück, um zu Bioleum Corporation zu wechseln.

false 0001120970 0001120970 2025-08-08 2025-08-08
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 8, 2025
 
 
COMSTOCK INC.
(Exact Name of Registrant as Specified in its Charter)
 
Nevada
001-35200
65-0955118
(State or Other
Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
 
117 American Flat Road, Virginia City, Nevada 89440
(Address of Principal Executive Offices, including Zip Code)
Registrant’s Telephone Number, including Area Code: (775) 847-5272
 
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.000666 per share
LODE
NYSE AMERICAN
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company      
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.      ☐
 
 

 
Item 1.01 Entry into a Material Definitive Agreement.
 
Amendments to Georges Trust and Alvin Fund Promissory Notes
 
On August 8, 2025, Comstock Inc. (the “Company” or “Comstock”) amended its outstanding promissory notes with its creditors, Georges Trust and Alvin Fund LLC (“Alvin Fund”), to address the procedures for the repayment of an aggregate of $8,390,000 in principal owed to such creditors pursuant to such promissory notes (together, the “Promissory Note Amendments”).  Pursuant to the Promissory Note Amendments, the Company issued an aggregate of 2,900,000 shares of Common Stock to such creditors as partial consideration to enter into such amendments (the “Debt Exchange”). The shares of Common Stock issued in connection with the Debt Exchange were issued as “restricted securities” as defined in Rule 144 under the Securities Act of 1933, as amended. The Company shall file a registration statement with respect to such shares for the benefit of the creditors as soon as practicable after, but in no event later than 90 days from the date of the Debt Exchange. To the extent a creditor is unable to sell the shares issued to it in connection with the Debt Exchange, or such shares have not otherwise been sold, in each case to generate net cash proceeds in an amount that would have been sufficient to repay the applicable promissory note in full, on or before April 15, 2026 (the “True-Up Date”), the Company is required to pay such creditors on the True-Up Date an amount equal to the total principal amounts payable for each respective promissory note upon maturity on the True-Up Date, minus (i) the net cash proceeds received by the applicable creditor from the sale of the shares of Common Stock by such creditor up to the True-Up Date, minus (ii) any and all cash payments made by the Company pursuant to the applicable promissory note up until the True-Up Date, plus (iii) any accrued interest on the principal amount underlying each promissory note at a rate of 12% per annum, calculated in accordance with the terms of the amendment. In the event the net cash proceeds received by the applicable creditor for the sale of their issued shares of Common Stock plus any cash payments made by the Company as of the True-Up Date exceeds the total amount payable to such creditor, the creditor must return all of such excess shares of Common Stock and cash, as applicable, to the Company.
 
Amendment to Warrants
 
On August 8, 2025, the Company amended certain outstanding common stock purchase warrants held by Georges Trust and Alvin Fund (the “Warrant Amendments”), whereby the Company agreed to extend the expiration date from December 31, 2025 to December 31, 2027 for (i) Georges Trust’s aggregate 100,000 warrants to purchase common stock, exercisable at $4.56 per share, issued pursuant to that certain (A) Common Stock Purchase Warrant, dated as of December 15, 2022, as amended on April 22, 2024, (B) Common Stock Purchase Warrant, dated as of December 15, 2022, as amended on April 22, 2024, and (C) Common Stock Purchase Warrant, dated as of August 22, 2022, as amended on April 22, 2024, and (ii) Alvin Fund’s 120,000 warrants to purchase common stock, exercisable at $4.56 per share, issued pursuant that certain Common Stock Purchase Warrant, dated as of November 12, 2023, as amended on April 22, 2024.
 
Kips Bay Select Payoff Agreement
 
On August 12, 2025, the Company entered into a payoff letter agreement (the “Payoff Agreement”), with Kips Bay Select, LP (“Kips Bay”), related to the Company’s obligations under its 6.0% Convertible Promissory Note due April 10, 2026, in the original aggregate principal amount of $10,638,298 (the “Note”). Pursuant to the Payoff Agreement, Kips Bay agreed to accept the payment of $2,500,000 in cash from the proceeds (the “Cash Payment Amount”) and the issuance of 447,724 shares of Common Stock, previously reserved and approved for issuance upon conversion of the Note (the “Payoff Shares”), in full satisfaction of the Company’s obligations under the Note (the satisfaction of the Note, the payment of the Cash Payment Amount and the issuance of the Payoff Shares are collectively referred to herein as the “Note Payoff”). In addition, Kips Bay agreed not to sell or trade any of the Payoff Shares on or prior to October 31, 2025.
 
The foregoing descriptions of the Promissory Note Amendments, Warrant Amendments and Payoff Agreement are qualified in their entirety by reference to the full text of the respective agreements, copies of which are filed as Exhibits 10.1, 10.2, 10.3, 10.4, 10.5 and 10.6 respectively, to this Current Report on Form 8-K and incorporated herein by reference.
 
Item 2.02 Results of Operations and Financial Condition.
 
On August 12, 2025, the Company disclosed preliminary financial results for the three- and six-month periods ended June 30, 2025.
 
The financial results described below are preliminary and subject to customary period end closing procedures, and, accordingly, could be subject to change wherein actual results may differ from the preliminary results described below.
 
•      As of and for the three and six-months ended June 30, 2025, the Company reported cash and cash equivalents of approximately $18.6 million, demonstrating the Company’s continued liquidity and ability to support its operational and strategic objectives.
 
•      During the three and six-months ended June 30, 2025, the Company recognized revenue of $0.3 million and $1.1 million, respectively. 
 
•      During the three and six-months ended June 30, 2025, the Company had recurring net losses of $7.8 million and $16.9 million, respectively.
 
The information provided in Item 2.02 of this Current Report on Form 8-K, is being furnished and shall not be deemed “filed” with for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. Such information shall not be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing, except as otherwise expressly set forth by specific reference in such filing.
 
Item 2.03 Creation of a Direct Financial Obligation or an Obligation Under an Off-Balance Sheet Arrangement of a Registrant.
 
The information provided in Item 1.01 under the heading “Kip’s Bay Select Payoff Agreement” is incorporated herein by reference.
 
Item 3.02 Unregistered Sales of Equity Securities.
 
The information included in Item 1.01 under the headings “Amendments to Georges Trust and Alvin Fund Promissory Notes” and “Kips Bay Select Payoff Agreement” is incorporated herein by reference.
 
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
David Winsness and Rahul Bobbili have each resigned as an officer, director and/or manager of Comstock entities to each join Bioleum Corporation.
 
Cautionary Note Regarding Forward-Looking Statements
 
This Current Report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. Any statements about the Company’s expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking. These statements are often, but are not always, made through the use of words or phrases such as “may,” “will,” “could,” “should,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “projects,” “potential,” “continue,” and similar expressions, or the negative of these terms. These forward-looking statements include statements about the Company’s preliminary financial results. Accordingly, these statements involve estimates, assumptions and uncertainties which could cause actual results to differ materially from those expressed in them. Any forward-looking statements are qualified in their entirety by reference to the risk factors detailed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, and in any of the Company’s subsequent filings with the Securities and Exchange Commission. Any forward-looking statements contained in Current Report on Form 8-K speak only as of the date hereof, and the Company disclaims any obligation or undertaking to update or revise any forward-looking statements contained in Current Report on Form 8-K, other than to the extent required by law.
 
Item 9.01 Financial Statements and Exhibits.
 
(d) Exhibits
 
Exhibit No.
 
Description
     
10.1
  Note Amendment Agreement, dated as of August 8, 2025, between the Company and Georges Trust
     
10.2   Note Amendment Agreement, dated as of August 8, 2025, between the Company and Alvin Fund LLC
     
10.3   Note Amendment Agreement, dated as of August 8, 2025, between the Company and Alvin Fund LLC
     
10.4   Omnibus Common Stock Purchase Second Warrant Amendment, dated as of August 8, 2025, between the Company and Georges Trust
     
10.5   Common Stock Purchase Warrant  Second Amendment, dated as of August 8, 2025, between the Company and Alvin Fund LLC
     
10.6   Payoff Letter Agreement, dated as of August 12, 2025, between the Company and Kips Bay Select, LP
     
104
 
Cover Page Interactive Data File (embedded within the Inline XBRL document).
 
 

 
 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
COMSTOCK INC.
     
Date: August 12, 2025
By:
 
/s/ Corrado De Gasperis
     
Corrado De Gasperis
Executive Chairman and Chief Executive Officer
 
 
 

FAQ

What did Comstock (LODE) do to address $8.39M of promissory notes?

Comstock issued an aggregate of 2,900,000 restricted shares to Georges Trust and Alvin Fund as partial consideration for $8,390,000 in principal and amended the repayment procedures, including a potential true-up on April 15, 2026 with 12% annual interest if needed.

How did Comstock settle the convertible note with Kips Bay?

Under the Payoff Agreement, Comstock agreed to pay $2,500,000 in cash and issue 447,724 shares to Kips Bay in full satisfaction of the original $10,638,298 convertible note; Kips Bay agreed to a lock-up until October 31, 2025.

What changes were made to outstanding warrants held by creditors?

Comstock extended Georges Trust’s aggregate 100,000 warrants and Alvin Fund’s 120,000 warrants exercisable at $4.56 per share to an expiration date of December 31, 2027.

What preliminary financial results did Comstock report for the quarter and six months ended June 30, 2025?

Preliminarily, Comstock reported $18.6 million in cash, revenue of $0.3 million for the quarter and $1.1 million for six months, and recurring net losses of $7.8 million (quarter) and $16.9 million (six months).

Will the shares issued in the debt exchange be registered?

The Company stated it will file a registration statement for the shares issued in the Debt Exchange as soon as practicable but no later than 90 days from the date of the Debt Exchange.

Did any officers or directors resign from Comstock?

Yes, David Winsness and Rahul Bobbili resigned as officers, directors and/or managers of Comstock entities to join Bioleum Corporation.
Comstock

NYSE:LODE

LODE Rankings

LODE Latest News

LODE Latest SEC Filings

LODE Stock Data

102.76M
28.22M
4.1%
7.49%
5.4%
Other Precious Metals & Mining
Industrial Organic Chemicals
United States
VIRGINIA CITY,